2021 domain 1 A008 adult inpatient & outpatient VE case control study
Ended Awarded Last action
- Contract number
- 75D30121F00002
- Awardee
-
Vanderbilt University Medical Center UEI GYLUH9UXHDX5
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $13,460,836
Award facts
- Contract value 100% obligated
- $13,460,835.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 622110 General Medical and Surgical Hospitals
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Nashville, TN 37232, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $500,000 | |
| Original award | $12,960,836 |
About this award
This is a $13,460,835.60 delivery order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Vanderbilt University Medical Center. The contract is for an Adult Inpatient and Outpatient VE Case Control Study, which will evaluate the effectiveness of COVID-19 and influenza vaccines. This order falls under the larger Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) indefinite delivery/indefinite quantity contract. The contract has no set-aside designation. Vanderbilt University Medical Center has subcontracted portions of the work to various academic and research institutions, including Wake Forest University Health Sciences, Baystate Medical Center, the University of Michigan, UCLA, the Washington University, Beth Israel Deaconess Medical Center, the Cleveland Clinic, and others. The study aims to assess vaccine effectiveness against symptomatic, medically-attended COVID-19 and influenza infections in high-risk adult populations.
Quick answers
Who was awarded contract 75D30121F00002?
75D30121F00002 was awarded to Vanderbilt University Medical Center by CDC Pittsburgh (Centers for Disease Control and Prevention) on February 5, 2021.
How much is contract 75D30121F00002 worth?
The government has obligated $13,460,836 on 75D30121F00002.
Is contract 75D30121F00002 an order under another contract?
Yes. 75D30121F00002 is a delivery order under HHSD200201691801I, an indefinite delivery contract, on Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016).
Was contract 75D30121F00002 competed?
The extent of competition for 75D30121F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award